Last updated 2026-07-20
Total raised
—
Last: Undisclosed Round 2025-09
Stage
Seed
Founded
2023
Headcount
5
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
EviCure is a preclinical-stage biopharmaceutical company that develops extracellular vesicle (EV)-based therapies for cancer treatment. The company leverages AI and experimental disease models to create EVs with anti-tumor properties or as vehicles for targeted drug delivery. Their platform aims to provide safe, cost-effective, mutation-agnostic, and stage-independent treatments for various solid tumors. Their first product, PL-Ex1, is an EV-based treatment for refractory NSCLC (Non-Small Cell Lung Cancer).
Headcount over time
5 employees (2026-09) · 1 point
Offices
Ness Ziona, Israel · HQ / main office
Q&A
- What is EviCure's primary focus?
- EviCure is developing an extracellular vesicle (EV)-based platform technology for cancer treatment, leveraging AI for anti-tumor effects against solid tumors.
- When was EviCure founded?
- EviCure was founded in February 2023.
- What is EviCure's total funding to date?
- EviCure has raised a total of $700,000.
- Which investor participated in EviCure's January 2024 funding round?
- Peregrine Ventures participated in EviCure's January 2024 funding round.
- What is the name of EviCure's first product?
- EviCure's first product on its platform is PL-Ex-1, which is being developed as an EV treatment against lung cancer.
- What technologies does EviCure utilize in its platform?
- EviCure utilizes Biologicals, Cells, and Artificial Intelligence in its platform.
- What is EviCure's current funding stage?
- EviCure is currently in the Seed funding stage.
Team · 2
Eric Messika
Founder · CEO & Co-Founder
Aharon Brodie
CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCellsArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
cancerpharmaceuticalscancer-therapybiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | evicure.com |
|---|---|
| linkedin.com/company/101462420 |
Identifiers & details
| Legal name | Evicure Ltd. |
|---|---|
| Founded | 2023 |
| Employees (exact) | 5 |
Radar intelligence
Publications (Crossref)
| Works | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516767019 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2023-02-13 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), shares_capital (1) |
| Registered address | מגדל ים 6 מודיעין-מכבים-רעות |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-25 | עדכון בעלי תפקידים |
| 2026-02-18 | הקצאת מניות |